Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)

Abstract excerpt

The parasitic disease human African trypanomiasis (HAT), also known as sleeping sickness, is a highly neglected fatal condition endemic in sub-Saharan Africa, which is poorly treated with medicines that are toxic, no longer effective or very difficult to administer. New, safe, effective and easy-to-use treatments are urgently needed. Many nitroimidazoles possess antibacterial and antiprotozoal activity and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Parasites and Host Interactions
• Share to Research on Leishmaniasis Studies
• Share to Trypanosoma species research and implications